Premium
Efficacy and safety of high‐dose peanut oral immunotherapy with factors predicting outcome
Author(s) -
Anagnostou K.,
Clark A.,
King Y.,
Islam S.,
Deighton J.,
Ewan P.
Publication year - 2011
Publication title -
clinical and experimental allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 154
eISSN - 1365-2222
pISSN - 0954-7894
DOI - 10.1111/j.1365-2222.2011.03699.x
Subject(s) - medicine , oral immunotherapy , peanut allergy , immunotherapy , maintenance dose , allergy , oral food challenge , immunoglobulin e , gastroenterology , immunology , food allergy , antibody , cancer
Peanut allergy is severe and rarely resolves.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom